Feedback
Settings

Settings

Goto Application

644 results
Offices all Languages en Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61B5/08 AND EN_ALLTXT:(coronavirus OR coronaviruses OR coronaviridae OR coronavirinae OR orthocoronavirus OR orthocoronaviruses OR orthocoronaviridae OR orthocoronavirinae OR betacoronavirus OR betacoronaviruses OR betacoronaviridae OR betacoronavirinae OR sarbecovirus OR sarbecoviruses OR sarbecoviridae OR sarbecovirinae OR "severe acute respiratory syndrome" OR sars OR "2019 ncov" OR covid)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 65
1.4218562REAL-TIME BREATH ANTIGEN DETECTION SYSTEM AND METHOD THEREOF
EP - 02.08.2023
Int.Class A61B 5/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
08Measuring devices for evaluating the respiratory organs
 Appl.No 22153898 Applicant UNIV BERLIN CHARITE Inventor BIEREWIRTZ TIM
The invention relates to a system for antigen detection comprising a first container configured to collect aerosols out of exhaled air of a human and a second container suitable for a solvent, wherein nanoparticles are dissolved in the solvent and the nanoparticles are linked to antibodies, further wherein a change of optical properties of the solvent is detectable upon contact between the antibodies and matching antigens. Here, a person can exhale air into the first container, and the aerosols exhaled in the air stick in a filter on one side of the first container. Thereupon, the first container is incooperable in the second container, in which a solvent with nanoparticles dissolved therein and antibodies coupled thereto are located. The incooperability, in particular a shuttling stroke motion, flushes the aerosols into the solvent. If antigens matching the antibodies are present on the aerosols, the nanoparticles agglomerate around the antigen, changing the optical properties of the solvent, which is irradiated by a light source and detectable by a light sensor.In further aspects, the invention relates to a method using the system according to the invention.The invention further relates to corresponding medical uses and therapeutic methods of administering a prevention of a medical condition associated with a SARS Coronavirus, in addition to diagnostic uses and methods.
2.WO/2023/144291REAL-TIME BREATH ANTIGEN DETECTION SYSTEM AND METHOD THEREOF
WO - 03.08.2023
Int.Class A61B 5/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
08Measuring devices for evaluating the respiratory organs
 Appl.No PCT/EP2023/051983 Applicant CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN Inventor BIEREWIRTZ, Tim
The invention relates to a system for antigen detection comprising a first container configured to collect aerosols out of exhaled air of a human and a second container suitable for a solvent, wherein nanoparticles are dissolved in the solvent and the nanoparticles are linked to antibodies, further wherein a change of optical properties of the solvent is detectable upon contact between the antibodies and matching antigens. Here, a person can exhale air into the first container, and the aerosols exhaled in the air stick in a filter on one side of the first container. Thereupon, the first container is incooperable in the second container, in which a solvent with nanoparticles dissolved therein and antibodies coupled thereto are located. The incooperability, in particular a shuttling stroke motion, flushes the aerosols into the solvent. If antigens matching the antibodies are present on the aerosols, the nanoparticles agglomerate around the antigen, changing the optical properties of the solvent, which is irradiated by a light source and detectable by a light sensor. In further aspects, the invention relates to a method using the system according to the invention. The invention further relates to corresponding medical uses and therapeutic methods of administering a prevention of a medical condition associated with a SARS Coronavirus, in addition to diagnostic uses and methods.
3.WO/2022/013877METHOD AND SYSTEM FOR PREPARING A SAMPLE FOR DETECTION OF PROTEINS
WO - 20.01.2022
Int.Class A61B 5/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
08Measuring devices for evaluating the respiratory organs
 Appl.No PCT/IL2021/050869 Applicant BREATH OF HEALTH LTD. Inventor LAOR, Marsel Arie
The present invention provides a system including a pump configured to pump an air sample, from a container to a cooling chamber, at a capacity of at least 0.5 liter/sec, the cooling chamber is configured to cool the exhaled air sample to a sub-zero temperature, and is in fluid connection to a spectrometer test chamber; an inert gas source, configured to supply an inert gas to the test chamber at a pressure higher than the atmospheric pressure; and a heating unit for heating said air sample. Further provided is a method for preparing an air sample for detection of a mixture of proteins.
4.WO/2021/222237DETECTION OF VIRUSES IN FACEMASKS
WO - 04.11.2021
Int.Class A61B 5/097
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
08Measuring devices for evaluating the respiratory organs
097Devices for facilitating collection of breath or for directing breath into or through measuring devices
 Appl.No PCT/US2021/029384 Applicant CAMAS INCORPORATED Inventor SIMPLOT, Scott
Facemasks with an integrated virus detection system are described. The virus detection system is embedded in or on a facemask worn by an individual susceptible to a viral infection. The individual wears a facemask for protective purposes during work or leisure. If the individual develops a viral infection and begins discharging viral particles from mouth and/or nose, the virus detection system embedded in the facemask retains the virus particles. The virus particles are detected in an immunoassay. The virus particles in the virus detection system embedded in the facemask are detected by avian antibodies. The virus detection system in the facemask is configured to detect one or more viruses, for example, SARS-CoV-2.
5.202227062840DETECTION OF VIRUSES IN FACEMASKS
IN - 03.02.2023
Int.Class A61B 5/097
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
08Measuring devices for evaluating the respiratory organs
097Devices for facilitating collection of breath or for directing breath into or through measuring devices
 Appl.No 202227062840 Applicant CAMAS INCORPORATED Inventor SIMPLOT, Scott
Facemasks with an integrated virus detection system are described. The virus detection system is embedded in or on a facemask worn by an individual susceptible to a viral infection. The individual wears a facemask for protective purposes during work or leisure. If the individual develops a viral infection and begins discharging viral particles from mouth and/or nose, the virus detection system embedded in the facemask retains the virus particles. The virus particles are detected in an immunoassay. The virus particles in the virus detection system embedded in the facemask are detected by avian antibodies. The virus detection system in the facemask is configured to detect one or more viruses, for example, SARS-CoV-2.
6.3177290DETECTION OF VIRUSES IN FACEMASKS
CA - 04.11.2021
Int.Class A61B 5/097
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
08Measuring devices for evaluating the respiratory organs
097Devices for facilitating collection of breath or for directing breath into or through measuring devices
 Appl.No 3177290 Applicant CAMAS INCORPORATED Inventor SIMPLOT, SCOTT
Facemasks with an integrated virus detection system are described. The virus detection system is embedded in or on a facemask worn by an individual susceptible to a viral infection. The individual wears a facemask for protective purposes during work or leisure. If the individual develops a viral infection and begins discharging viral particles from mouth and/or nose, the virus detection system embedded in the facemask retains the virus particles. The virus particles are detected in an immunoassay. The virus particles in the virus detection system embedded in the facemask are detected by avian antibodies. The virus detection system in the facemask is configured to detect one or more viruses, for example, SARS-CoV-2.
7.WO/2021/207184USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19
WO - 14.10.2021
Int.Class A61B 5/087
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
08Measuring devices for evaluating the respiratory organs
087Measuring breath flow
 Appl.No PCT/US2021/025950 Applicant BELLEROPHON THERAPEUTICS Inventor SHAH, Parag
The present disclosure relates to use of pulsed dose inhaled nitric oxide for treatment of infection, including infection with SARS-CoV2 and the disease state COVID-19.
8.WO/2022/248936DEVICE AND METHOD FOR DETECTING A COMPONENT OF EXHALED BREATH CONDENSATE
WO - 01.12.2022
Int.Class A61B 5/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
08Measuring devices for evaluating the respiratory organs
 Appl.No PCT/IB2022/000302 Applicant EXHALATION TECHNOLOGY LTD Inventor BREJL, Stig, Lytke
Aspects relate to a system for collecting condensate from exhaled breath and performing a test to analyze presence of a virus in the collected condensate. The system may include a disposable for collecting the condensate and a reusable electronic device for performing the test. In some embodiments, a user may exhale into the disposable and the electronic device provides the user with a result of the test indicating whether the user is infected with the virus. The virus detected may be severe acute respiratory syndrome coronavims 2 (SARS-CoV-2), the virus that causes COVID-19 (coronavims disease 2019). Additional aspects relate to determining a fill state of a sensor associated with collection of the exhaled breath condensate, calibration and function testing of the system used for determining a presence of a virus in the exhaled breath condensate and reading identifying information stored on the disposable used for collecting the exhaled breath condensate.
9.20230158064USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19
US - 25.05.2023
Int.Class A61K 33/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
 Appl.No 17917209 Applicant BELLEROPHON THERAPEUTICS Inventor Parag SHAH

The present disclosure relates to use of pulsed dose inhaled nitric oxide for treatment of infection, including infection with SARS-CoV2 and the disease state COVID-19.

10.4163397SPECIMEN TRANSPORT KIT FOR DETECTING RESPIRATORY PATHOGENS AND METHODS FOR DETECTING RESPIRATORY PATHOGENS USING SAME
EP - 12.04.2023
Int.Class C12Q 1/70
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
70involving virus or bacteriophage
 Appl.No 21816989 Applicant SEEGENE INC Inventor CHUN JONG YOON
The present invention relates to a specimen transport kit for detecting respiratory pathogens, which is configured to collect both a nasopharyngeal cavity specimen and a salivary specimen in a swab method and make a specimen transport medium impregnated with the specimens together, and a method for detecting respiratory pathogens using same. The present invention provides a higher positive rate and more accurate diagnostic results for respiratory pathogens than when the nasopharyngeal cavity specimen or the salivary specimen is used separately.
# -